Another new drug. Enzalutamide (xtandi) was approved by the fda. This drug joins sipuleucel-t (provenge), abiratarone (zytiga) and cabzitaxel as drugs that improve overall survival in patients with advanced prostate cancer. Another drug, radium 223, (xofigo) was just approved that targets cancer in bone and improve survival. Prostvac is a vaccine that is in phase 3 clinical trials.
Prostate ca drugs. Jevtana, zytiga, (abiraterone acetate) Provenge are new drugs available in the market for prostate cancer. Mvd-3100- soon would also be availabe in the market as the independent data monitoring committee (idmc) had recommended ending the phase 3 trial early due to extremely positive efficacy- using mvd-3100. http://www.drugs.com/jevtana.html http://www.Drugs.Com/zytiga.Html http://www.Drugs.Com/provenge.Html.